Media Room
Explore our latest press releases, announcements, and updates on groundbreaking immunotherapy research.
For media inquiries, please contact us at [email protected].
-
Media Room Article
Cellular Cancer Immunotherapy Development Evolves, Expands with New Technologies and Targets
Latest analysis from the Cancer Research Institute of the global landscape of cellular immunotherapies, including R&D trends…
-
Media Room Article
Cancer Research Institute Hosts 10th Annual Cancer Immunotherapy Month™ Celebrating Lifesaving Discovery in Immuno-Oncology
Awareness and educational program offerings for cancer patients and caregivers about the latest advances in cancer immunotherapy…
-
Media Room Article
First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
First patients dosed in phase 2 platform clinical trial testing novel immunotherapy combinations in highly malignant ovarian…
-
Media Room Article
Cancer Immunotherapy Clinical Trials Continue to Grow Globally, Combination Approaches Outpace Monotherapy Trials
CRI’s latest analysis of the PD1/PDL1 immuno-oncology landscape confirms trends in trial design and patient enrollment, points…
-
Media Room Article
Cancer Research Institute to Honor Developers of COVID-19 mRNA Vaccines in Historic Gathering: “This Technology Will Play a Big Role in Cancer Treatment”
Four Key Scientists Behind the Vaccines to Share Virtual Stage at November 10 Event; Katalin Karikó, Ugur…
-
Media Room Article
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial
The first patients have enrolled in a platform clinical trial, called REVOLUTION, testing combination immunotherapy in patients…
-
Media Room Article
CRI Immunotherapy Summit Grows Along with Cancer Treatment Prospects
CRI's free and live online event for patients and caregivers covering cancer immunotherapy, clinical trials, and cancer…
-
Media Room Article
Ana Patricia Gámez Joins Cancer Research Institute in the Movement for Racial Health Equity, Named Moderator of First Spanish-Language Virtual Cancer Immunotherapy Summit
CRI’s free virtual event to connect U.S. Hispanic cancer patients and caregivers with leading cancer experts to…
-
Media Room Article
Ana Patricia Gámez Se Une Al Cancer Research Institute En Su Compromiso Por La Igualdad Racial En El Cuidado De La Salud, Como Presentadora De La Primera Conferencia Virtual En Español Sobre Inmunoterapia Contra El Cáncer
El evento virtual y gratuito del CRI que conectará a pacientes y cuidadores hispanos
en Estados Unidos…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.